This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

GSK 719125

GlaxoSmithKline plc

Drug Names(s): Her-2/neu T-cell vaccine, Her2/neu T-cell vaccine

Description: Corixa's HER-2/neu is an encapsulated Her-2/neu peptide p369-377 in poly(lactide-co-glycolide) microspheres used as a breast cancer vaccine. This immunotherapy is based upon a cancer antigen that was developed during a vaccine discovery collaboration with GSK.

In May 2005, GSK announced it would acquire Corixa.

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug